Pfizer applies for authorization of omicron-retooled booster in kids under 5

Pfizer Inc. and its German partner BioNTech SE have applied to the U.S. Food and Drug Administration for emergency use authorization of their COVID-19 vaccine booster for children aged 6 months through 4 years.

>> Read more trending news

The bivalent vaccine targets the original strain of the COVID-19 virus, plus the BA.4 and BA.5 omicron subvariants.

An authorization from the FDA would mean that children would receive the primary vaccine series — two doses of the original Pfizer-BioNTech COVID-19 vaccine — and then one shot of the omicron-adapted bivalent vaccine.

The omicron BA.4/BA.5-adapted bivalent COVID-19 vaccine was authorized as a booster dose for ages 5 years and older in the U.S. in October.

On AirWMMO - Orlando's Classic Hits Logo

mobile apps

Everything you love about and more! Tap on any of the buttons below to download our app.

amazon alexa

Enable our Skill today to listen live at home on your Alexa Devices!